vTv Therapeutics (VTVT) Other Non-Current Assets (2014 - 2026)

vTv Therapeutics has disclosed Other Non-Current Assets across 10 years of filings, most recently posting $5000.0 for Q1 2026.

• Other Non-Current Assets for Q1 2026 came in at $5000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $5000.0 (changed N/A YoY), and the FY2025 annual result was $6000.0, down 96.08% from the prior year.
• Other Non-Current Assets came in at $5000.0 for Q1 2026 at vTv Therapeutics, down from $6000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $153000.0 in Q4 2024 to a low of $5000.0 in Q1 2026.
• The 3-year median for Other Non-Current Assets is $6000.0 (2025), against an average of $54666.7.
• Peak annual rise in Other Non-Current Assets reached 96.08% in 2025, while the deepest fall reached 96.08% in 2025.
• vTv Therapeutics' Other Non-Current Assets stood at $153000.0 in 2024, then tumbled by 96.08% to $6000.0 in 2025, then dropped by 16.67% to $5000.0 in 2026.
• The last three Other Non-Current Assets figures came in at $5000.0 (Q1 2026), $6000.0 (Q4 2025), and $153000.0 (Q4 2024), per Business Quant data.